Protein synthesis rate measured with L-[1-11C]tyrosine positron emission tomography correlates with mitotic activity and MIB-1 antibody-detected proliferation in human soft tissue sarcomas

European Journal of Nuclear Medicine

Volumn 26, Issue 4, 1999, Pages 328-332

  Plaat, Boudewijn ^a   Kole, Annemieke ^b   Mastik, Mirjam ^b   Hoekstra, Harald ^b   Molenaar, Willemina ^b   Vaalburg, Willem ^b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b NONE

Author keywords

Mitotic activity proliferation; Positron emission tomography; Protein synthesis rate; Soft tissue sarcoma

Indexed keywords

CARBON 11; CELL NUCLEUS ANTIGEN; KI 67 ANTIGEN; MONOCLONAL ANTIBODY KI 67;

ADULT; AGED; ARTICLE; CANCER GRADING; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; ISOTOPE LABELING; MALE; MITOSIS RATE; POSITRON EMISSION TOMOGRAPHY; PROTEIN SYNTHESIS; SOFT TISSUE SARCOMA; TUMOR BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES; ANTIGENS, NUCLEAR; CELL DIVISION; FEMALE; HUMANS; KI-67 ANTIGEN; KINETICS; MALE; MIDDLE AGED; MITOSIS; NUCLEAR PROTEINS; PROTEIN BIOSYNTHESIS; RADIOPHARMACEUTICALS; SARCOMA; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TYROSINE;

EID: 0032947907     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590050394     Document Type: Article

References (30)

1. 1. Enzinger FM, Weiss SW. Soft tissue tumors. St. Louis: C.V. Mosby, 1995.
2. 2. Coindre JM, Terrier P, Bui NB, Bonichon F, Collin F, Le Doussal V, Mandard AM, Vilain MO, Jacquemier J, Duplay H, Sastre X, Barlier C, Henry Amar M, Mace Lesech J, Contesso G. Prognostic factors in adult patients with locally controlled soft tissue sarcoma. A study of 546 patients from the French Federation of Cancer Centers Sarcoma Group. J Clin Oncol 1996; 14: 869-877.
3. 3. Rossi CR, Foletto M, Alessio S, Menin N, D'Amore E, Rigon A, Lise M. Limb-sparing treatment for soft tissue sarcomas: influence of prognostic factors. J Surg Oncol 1996; 63: 3-8.
4. 4. Choong PF, Akerman M, Willen H, Andersson C, Gustafson P, Baldetorp B, Ferno M, Alvegard T, Rydholm A. Prognostic value of Ki-67 expression in 182 soft tissue sarcomas. Proliferation - a marker of metastasis? APMIS 1994; 102: 915-924.
5. 5. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H. Cell cycle analysis of a cell proliferation associated human nuclear antigen defined by the monoclonal antibody Ki67. J Immunol 1984; 133: 1710-1715.
6. 6. Adler LP, Blair HF, Makley JT, Williams RP, Joyce MJ, Leisure G, al Kaisi N, Miraldi F. Noninvasive grading of musculoskeletal tumors using PET. J Nucl Med 1991; 32: 1508-1512.
7. 7. Nieweg OE, Pruim J, van Ginkel RJ, Hoekstra HJ, Paans AMJ, Molenaar WM, Schraffordt Koops H, Vaalburg W. Fluorine-18-fluorodeoxyglucose PET imaging of soft-tissue sarcoma. J Nucl Med 1996; 37: 257-261.
8. 8. van Ginkel RJ, Hoekstra HJ, Pruim J, Nieweg OE, Molenaar WM, Paans AMJ, Willemsen AT, Vaalburg W, Schraffordt Koops H. FDG-PET to evaluate response to hyperthermic isolated limb perfusion for locally advanced soft-tissue sarcoma. J Nucl Med 1996; 37: 984-990.
9. 11C]-tyrosine and PET. J Nucl Med 1995; 36: 411-419.
10. 10. Paans AMJ, Pruim J, van Waarde A, Willemsen ATM, Vaalburg W. Radiolabelled-tyrosine for the measurement of protein synthesis rate in vivo by positron emission tomography. Baillieres Clin Endocrinol Metab 1996; 10: 497-510.
11. 11C]tyrosine PET. J Nucl Med 1997; 38: 692-696.
12. 12. Kole AC, Pruim J, Nieweg OE, van Ginkel RJ, Hoekstra HJ, Schraffordt Koops H, Vaalburg W. PET with L-[1-carbon-11]-tyrosine to visualize tumors and measure protein synthesis rates. J Nucl Med 1997; 38: 191-195.
13. 11C]tyrosine PET. J Nucl Med 1997; 38: 1369-1374.
14. 14. Coindre JM, Trojani M, Contesso G, David M, Rouesse J, Bui NB, Bodaert A, De Mascarel I, de Mascarel A, Goussot JF. Reproducibility of a histopathologic grading system for adult soft tissue sarcoma. Cancer 1986; 58: 306-309.
15. 15. Shi SR, Key ME, Kalra KL. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 1991; 39: 741-748.
16. 16. Emanuels A, Hollema H, Koudstaal J. Autoclave heating: an alternative method for microwaving? Eur J Morph 1994; 32: 337-340.
17. 17. Kroese MC, Rutgers DH, Wils IS, van Unnik JA, Roholl PJ. The relevance of the DNA index and proliferation rate in the grading of benign and malignant soft tissue tumors. Cancer 1990; 65: 1782-1788.
18. 18. Jochum W, Schroder S, al Taha R, August C, Gross AJ, Berger J, Padberg BC. Prognostic significance of nuclear DNA content and proliferative activity in renal cell carcinomas. A clinicopathologic study of 58 patients using mitotic count, MIB-1 staining, and DNA cytophotometry. Cancer 1996; 77: 514-521.
19. 19. Youssef EM, Matsuda T, Takada N, Osugi H, Higashino M, Kinoshita H, Watanabe T, Katsura Y, Wanibuchi H, Fukushima S. Prognostic significance of the MIB-1 proliferation index for patients with squamous cell carcinoma of the esophagus. Cancer 1995; 76: 358-366.
20. 20. Jensen V, Ladekarl M, Holm Nielsen P, Melsen F, Soerensen FB. The prognostic value of oncogenic antigen 519 (OA-519) expression and proliferative activity detected by antibody MIB-1 in node-negative breast cancer. J Pathol 1995; 176: 343-352.
21. 21. Albers P, Orazi A, Ulbright TM, Miller GA, Haidar JH, Donohue JP, Foster RS. Prognostic significance of immunohistochemical proliferation markers (Ki-67/MIB-1 and proliferation-associated nuclear antigen), p53 protein accumulation, and neovascularization in clinical stage A nonseminomatous testicular germ cell tumors. Mod Pathol 1995; 8: 492-497.
22. 22. Ramsay JA, From L, Iscoe NA, Kahn HJ. MIB-1 proliferative activity is a significant prognostic factor in primary thick cutaneous melanomas. J Invest Dermatol 1995; 105: 22-26.
23. 23. Rudolph P, Kellner U, Chassevent A, Collin F, Bonichon F, Parwaresch R, Coindre JM. Prognostic relevance of a novel proliferation marker, Ki-S11, for soft-tissue sarcoma. A multivariate study. Am J Pathol 1997; 150: 1997-2007.
24. 24. Van Unnik JA, Coindre JM, Contesso C, Albus Lutter CE, Schiodt T, Sylvester R, Thomas D, Bramwell V, Mouridsen HT. Grading of soft tissue sarcomas: experience of the EORTC Soft Tissue and Bone Sarcoma Group. Eur J Cancer 1993; 29 A: 2089-2093.
25. 25. Alberts B, Bray D, Lewis J, Raff M, Roberts K, Watson JD. The cell-division cycle. In: Robertson M, Adams R, Cobert SM, eds. Molecular biology of the cell. New York: Garland; 1994: 863-910.
26. 18F]FDG. J Comput Assist Tomogr 1990; 14: 960-962.
27. 27. Kern KA, Brunetti A, Norton JA, Chang AE, Malawer M, Lack E, Finn RD, Rosenberg SA, Larson SM. Metabolic imaging of human extremity musculoskeletal tumors by PET. J Nucl Med 1988; 29: 181-186.
28. 28. Willett CG, Warland G, Hagan MP, Daly WJ, Coen J, Shellito PC, Compton CC. Tumor proliferation in rectal cancer following preoperative irradiation. J Clin Oncol 1995; 13: 1417-1424.
29. 29. Garzetti GG, Ciavattini A, Lucarini G, Goteri G, De Nictolis M, Romanini C, Biagini G. Modulation of expression of p53 and cell proliferation in locally advanced cervical carcinoma after neoadjuvant combination chemotherapy. Eur J Obstet Gynecol Reprod Biol 1995; 63: 31-36.
30. 30. Honkoop AH, Pinedo HM, De Jong JS, Verheul HM, Linn SC, Hoekman K, Wagstaff J, van Diest PJ. Effects of chemotherapy on pathologic and biologic characteristics of locally advanced breast cancer. Am J Clin Pathol 1997; 107: 211-218.